IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction

Annals of the Rheumatic Diseases

Volumn 71, Issue 4, 2012, Pages 596-605

  Bussone, Guillaume ^a,b   Tamby, Mathieu C ^a,b   Calzas, Cynthia ^a,b   Kherbeck, Nada ^a,b   Sahbatou, Younes ^a,b   Sanson, Claire ^a,b   Ghazal, Khaldoun ^a,b   Dib, Hanadi ^a,b   Weksler, Babette B ^c   Broussard, Cédric ^a,b   Verrecchia, Franck ^d   Yaici, Azzedine ^e,f   Witko Sarsat, Véronique ^a,b   Simonneau, Gérald ^e,f   Guillevin, Loïc ^b   Humbert, Marc ^e,f   Mouthon, Luc ^a,b  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITÉ DE NANTES   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; COLLAGEN; IMMUNOGLOBULIN G ANTIBODY; PHOSPHOPROTEIN; PHOSPHOPROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MUSCLE FIBER CONTRACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; SYSTEMIC SCLEROSIS; VASCULAR SMOOTH MUSCLE;

ADULT; AGED; AUTOANTIGENS; CELLS, CULTURED; COLLAGEN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEAT-SHOCK PROTEINS; HUMANS; HYPERTENSION, PULMONARY; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 84857916567     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200195     Document Type: Article

References (31)

1. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-63.
2. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54(1 Suppl):S43-54.
3. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004;351:1655-65.
4. Kherbeck N, Tamby MC, Bussone G, et al. The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension. Clin Rev Allergy Immunol 2011; Mar 2011. [Epub ahead of print]. doi:10.1007/s12016-011- 8265-z.
5. Morrell NW, Adnot S, Archer SL, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54(1 Suppl):S20-31.
6. Hassoun PM, Mouthon L, Barberà JA, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 2009;54(1 Suppl):S10-9.
7. Tuder RM, Groves B, Badesch DB, et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994;144:275-85. (Pubitemid 24165948)
8. Mouthon L, Guillevin L, Humbert M. Pulmonary arterial hypertension: an autoimmune disease? Eur Respir J 2005;26:986-8. (Pubitemid 41829926)
9. Tamby MC, Chanseaud Y, Humbert M, et al. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 2005;60:765-72. (Pubitemid 41297897)
10. Tamby MC, Humbert M, Guilpain P, et al. Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension. Eur Respir J 2006;28:799-807. (Pubitemid 46332002)
11. Terrier B, Tamby MC, Camoin L, et al. Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension. Am J Respir Crit Care Med 2008;177:1128-34. (Pubitemid 351717572)
12. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
13. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5. (Pubitemid 18073738)
14. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
15. Weksler BB, Subileau EA, Perrière N, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005;19:1872-4. (Pubitemid 41598779)
16. Baiu DC, Barger B, Sandor M, et al. Autoantibodies to vascular smooth muscle are pathogenic for vasculitis. Am J Pathol 2005;166:1851-60. (Pubitemid 40734407)
17. Ogawa F, Shimizu K, Hara T, et al. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage. Arch Dermatol Res 2010;302:27-35.
18. Riemekasten G, Philippe A, Näther M, et al. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis 2011;70:530-6.
19. Grader-Beck T, Boin F, von Gunten S, et al. Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease. Ann Rheum Dis 2011; Published Online First: 26 August 2011 doi:10.1136/ard.2011.153130.
20. Lepetit H, Eddahibi S, Fadel E, et al. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J 2005;25:834-42. (Pubitemid 40667681)
21. Goëb V, Thomas-L'Otellier M, Daveau R, et al. Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes. Arthritis Res Ther 2009;11:R38.
22. Kim S, Cho H, Nam EJ, et al. Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer. Genes Chromosomes Cancer 2010;49:585-95.
23. Chizzolini C, Raschi E, Rezzonico R, et al. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum 2002;46:1602-13. (Pubitemid 34620208)
24. Bordron A, Dueymes M, Levy Y, et al. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 1998;101:2029-35. (Pubitemid 28244086)
25. Hocking DC, Sottile J, Langenbach KJ. Stimulation of integrin-mediated cell contractility by fibronectin polymerization. J Biol Chem 2000;275:10673-82. (Pubitemid 30202135)
26. Moodie FD, Leaker B, Cambridge G, et al. Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis. Kidney Int 1993;43:675-81. (Pubitemid 23071952)
27. Servettaz A, Guilpain P, Camoin L, et al. Identification of target antigens of antiendothelial cell antibodies in healthy individuals: A proteomic approach. Proteomics 2008;8:1000-8. (Pubitemid 351441439)
28. Terrier B, Tamby MC, Camoin L, et al. Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease. Ann Rheum Dis 2010;69:428-33.
29. Bussone G, Mouthon L. Interstitial lung disease in systemic sclerosis. Autoimmun Rev 2011;10:248-55.
30. Bussone G, Dib H, Tamby MC, et al. Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis. Arthritis Res Ther 2011;13:R74.
31. Bussone G, Dib H, Dimitrov JD, et al. Identification of target antigens of self-reactive IgG in intravenous immunoglobulin preparations. Proteomics 2009;9:2253-62.